CLOCK is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression

被引:70
作者
Oishi, K.
Ohkura, N.
Wakabayashi, M.
Shirai, H.
Sato, K.
Matsuda, J.
Atsumi, G.
Ishida, N.
机构
[1] Natl Inst Adv Ind Sci & Technol, Clock Cell Biol Res Grp, Tsukuba, Ibaraki 3058566, Japan
[2] Teikyo Univ, Fac Pharmaceut Sci, Dept Clin Mol Biol, Kanagawa, Japan
[3] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan
关键词
adipose tissue; circadian clock; Clock mutant mouse; ob/ob mouse; obesity; plasminogen activator inhibitor-1;
D O I
10.1111/j.1538-7836.2006.02032.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: An increased level of obesity-induced plasma plasminogen activator inhibitor-1 (PAI-1) is considered a risk factor for cardiovascular disease. Aim: The present study investigates whether the circadian clock component CLOCK is involved in obesity-induced PAI-1 elevation. Methods: We examined plasma PAI-1 and mRNA expression levels in tissues from leptin-deficient obese and diabetic ob/ob mice lacking functional CLOCK protein. Results: Our results demonstrated that plasma PAI-1 levels were augmented in a circadian manner in accordance with the mRNA expression levels in ob/ob mice. Surprisingly, a Clock mutation normalized the plasma PAI-1 concentrations in accordance with the mRNA levels in the heart, lung and liver of ob/ob mice, but significantly increased PAI-1 mRNA levels in adipose tissue by inducing adipocyte hypertrophy in ob/ob mice. The Clock mutation also normalized tissue PAI-1 antigen levels in the liver but not in the adipose tissue of ob/ob mice. Conclusion: These observations suggest that CLOCK is involved in obesity-induced disordered fibrinolysis by regulating PAI-1 gene expression in a tissue-dependent manner. Furthermore, it appears that obesity-induced PAI-1 production in adipose tissue is not closely related to systemic PAI-1 increases in vivo.
引用
收藏
页码:1774 / 1780
页数:7
相关论文
共 42 条
[1]   Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation [J].
Alessi, MC ;
Bastelica, D ;
Mavri, A ;
Morange, P ;
Berthet, B ;
Grino, M ;
Juhan-Vague, I .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (07) :1262-1268
[2]  
Alessi MC, 2004, ARCH MAL COEUR VAISS, V97, P673
[3]   Nuclear factor-κB suppressive and inhibitor-κB stimulatory effects of troglitazone in obese patients with type 2 diabetes:: Evidence of an antiinflammatory action? [J].
Aljada, A ;
Garg, R ;
Ghanim, H ;
Mohanty, P ;
Hamouda, W ;
Assian, E ;
Dandona, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) :3250-3256
[4]   CIRCADIAN VARIATION OF FIBRINOLYTIC-ACTIVITY IN BLOOD [J].
ANDREOTTI, F ;
KLUFT, C .
CHRONOBIOLOGY INTERNATIONAL, 1991, 8 (05) :336-351
[5]   Regulation of prokineticin 2 expression by light and the circadian clock [J].
Cheng, MY ;
Bittman, EL ;
Hattar, S ;
Zhou, QY .
BMC NEUROSCIENCE, 2005, 6 (1)
[6]   Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease [J].
De Taeye, B ;
Smith, LH ;
Vaughan, DE .
CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (02) :149-154
[7]   DEVELOPMENT OF OBESITY, HYPERINSULINEMIA, AND HYPERGLYCEMIA IN OB-OB MICE [J].
DUBUC, PU .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1976, 25 (12) :1567-1574
[8]   Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus [J].
Fonseca, VA ;
Reynolds, T ;
Hemphill, D ;
Randolph, C ;
Wall, J ;
Valiquet, TR ;
Graveline, J ;
Fink, LM .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1998, 12 (04) :181-186
[9]   Suppression of nuclear factor-κB and stimulation of inhibitor κB by troglitazone:: Evidence for an antiinflammatory effect and a potential antiatherosclerotic effect in the obese [J].
Ghanim, H ;
Garg, R ;
Aljada, A ;
Mohanty, P ;
Kumbkarni, Y ;
Assian, E ;
Hamouda, W ;
Dandona, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1306-1312
[10]   Circadian rhythm in the cardiovascular system: Chronocardiology [J].
Guo, YF ;
Stein, PK .
AMERICAN HEART JOURNAL, 2003, 145 (05) :779-786